IRVING, Texas -- Novation, a leading healthcare contracting services company of VHA Inc., University HealthSystem Consortium (UHC) and Provista, LLC., and Becton Dickinson (BD) announced today that they have agreed to add the BD GeneOhm molecular products to the microbiology portfolio effective April 15, 2008. This includes the PCR instrument and assays for hospital surveillance of methicillin-resistant Staphylococcus aureus (MRSA). The identification and control of hospital-acquired infections (HAIs) have become an important initiative for facilities.
“The BD GeneOhm molecular-based test is a cost-effective and efficient way for a medium to high volume screening program,” said, Cheryl Mason, portfolio executive at Novation.
Novation recently launched its MRSA Solutions Set, a comprehensive online resource program that provides healthcare workers with contract solutions available through Novation’s extensive portfolio to prevent, detect and treat the infection. The program is designed to be a one-stop, all-inclusive repository of Novation contracts, supplier resources, and industry-approved clinical guidelines. The resource is part of a larger infection control portfolio which provides support for members in their fight against all HAIs.
Source: Novation
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
The Clean Bite: Real Talk About Infection Control — From the Classroom to the Operatory
August 5th 2025Want dental assistants who don’t just know infection control, but live it from day one? Tune in to The Clean Bite and learn how powerhouse instructor Samantha Mangioni is shaping the next generation to protect every patient, every time.
Sharps Safety Starts with Us: Why Infection Preventionists Must Lead the Charge
August 5th 2025Sharps injuries remain a silent but serious threat in health care that infection preventionists are uniquely equipped to confront. With underreporting widespread and safety devices underused, it’s time for IPs to step into a leadership role, using their expertise in systems thinking, education, and policy to build a culture where staff protection is as prioritized as patient care.
Rethinking Clean: How Outdated Disinfection Practices Are Fueling the AMR Crisis
August 5th 2025As drug-resistant infections rise, infection preventionists must look beyond outdated disinfectants. HOCl offers a safer, sustainable solution that has been proven effective, residue-free, and ready for health care use today.
Is the US Quietly Ending COVID-19 Vaccination for the Young and Healthy
August 5th 2025As the FDA limits COVID-19 vaccine approvals to high-risk groups, healthy adults and pregnant individuals are being left behind. Learn how these changes could impact insurance coverage, long COVID prevention, and public health strategies.